Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Graft versus host disease – a rare complication after liver transplantation

M Markiewicz-Kijewska, J Teisseyre, P Kaliciński, P Kluge, M Teisseyre

Ann Transplant 2009; 14(1): 42-42 :: ID: 880352


Background: Graft versus host disease after liver transplantation develops extremely rare, but always is a life threatening complication. In the literature we found about 85 cases reported until now that included 10 children. We report additional case of GvHD in a paediatric liver transplant recipient.
Case Report: 16 months old boy received living related donor (father) liver
transplantation after failed hapatoportoenterostomy due to congenital biliary atresia. Both, donor and recipient were of identical blood group and pre-transplant cross-match was negative. Primary immunosuppression consisted of tacrolimus and mycophenolate mofetil. Early post-transplant course was excellent, but after 7 weeks he developed mild upper respiratory distress which was treated with oral cephalosporin. Three days later he developed a skin rash followed by little blisters and ulcerative changes. There were no laboratory abnormalities but relative leucopenia, with increased number of eosinophils and CRP. Skin biopsy confirmed suspicion of graft versus host disease of grade II/III. Local therapy was introduced with colloid dressings and tacrolimus was discontinued, while corticosteroid boluses (5-10 mg/kg body mass) and daclizumab (1 mg/kg body mass) were started. Despite that, further deterioration was observed and we decided to treat the child with ATG, however the child died of MOF after next 9 days despite all possible intensive therapy.
Conclusions: GvHD is very serious complication with high mortality rate. There is no standard for the effective therapy of problem.

Keywords: Liver Transplantation, case report

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358